Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation-Reference-Cited by-同舟云学术

Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation

Published:2019-08-21 Issue:8 Volume:14 Page:e0220408
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nebot Giralt Ariadna,Nöstlinger Christiana,Lee Janice,Salami Olawale,Lallemant Marc,Onyango-Ouma Washington,Nyamongo Isaac,Marchal Bruno^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. WHO. The use of antiretroviral drugs for treating and preventing HIV infection. WHO consolidated guidelines. 2013.

2. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia;S Biadgilign;BMC Pediatr

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda;AIDS and Behavior;2024-07-11

2. Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1–infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study;Antiviral Therapy;2024-04

3. Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study;BMC Health Services Research;2023-10-16

4. Drug Formulation for Pediatric Oral Antimicrobial Agents in Japan: Current Status, Prospects, and Challenges;Pediatric Infectious Disease Journal;2023-05-29

5. Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver–child dyads’ perspective;Therapeutic Advances in Infectious Disease;2023-01